Peripheral artery disease (PAD) has become a growing global healthcare concern due to increasing rates of diabetes, obesity, aging populations, and cardiovascular risk factors. The condition occurs when plaque buildup narrows or blocks arteries, reducing blood flow to the limbs and increasing the risk of serious complications. As awareness of vascular health increases, healthcare providers are adopting advanced treatment solutions that improve circulation while reducing procedural risks. The rising demand for atherectomy devices market solutions, expansion of the cardiovascular disease market, and increasing adoption of minimally invasive vascular procedures are significantly contributing to the growth of the Peripheral Artery Disease Market.
The global peripheral artery disease market size was valued at USD 5.11 billion in 2024 and is projected to expand at a CAGR of 7.5% from 2025 to 2034. The market is expected to reach USD 5.49 billion in 2025 and further grow to approximately USD 10.53 billion by 2034.
Atherectomy Devices Market Driving Advanced PAD Treatment
The atherectomy devices market is becoming an important segment within vascular intervention as these devices provide an effective approach for removing plaque buildup from blocked arteries. Unlike traditional approaches that only compress plaque against the arterial wall, atherectomy systems are designed to remove or modify atherosclerotic lesions, helping restore blood flow.
Atherectomy devices are commonly used for treating:
- Peripheral artery disease
- Coronary artery disease
- Below-the-knee arterial blockages
- Complex vascular lesions
Different types of atherectomy technologies include:
- Directional atherectomy systems
- Rotational atherectomy systems
- Orbital atherectomy systems
- Laser atherectomy systems
These technologies help physicians manage complex vascular conditions with greater precision. Continuous improvements in device design, imaging integration, and catheter technology are enhancing procedural outcomes and expanding clinical applications.
Cardiovascular Disease Market Increasing Demand for Vascular Solutions
The growing cardiovascular disease market is a major factor supporting the expansion of peripheral artery disease treatment technologies. Cardiovascular diseases remain among the leading causes of mortality worldwide, with conditions such as atherosclerosis, coronary artery disease, and peripheral vascular disease affecting millions of patients.
Several risk factors are contributing to the increasing burden of cardiovascular diseases, including:
- Aging population
- Diabetes prevalence
- High cholesterol levels
- Hypertension
- Sedentary lifestyles
- Obesity
As cardiovascular disease rates continue to rise, healthcare systems are focusing on early diagnosis, preventive care, and minimally invasive interventions. Advanced vascular devices, including atherectomy systems, play a crucial role in improving treatment outcomes for patients with arterial blockages.
The integration of imaging technologies such as intravascular ultrasound and advanced angiography systems is further improving treatment accuracy and enabling physicians to customize procedures based on individual patient needs.
Minimally Invasive Vascular Procedures Transforming Patient Care
The increasing adoption of minimally invasive vascular procedures is reshaping the treatment landscape for peripheral artery disease. Compared with traditional open surgical approaches, minimally invasive interventions provide several benefits, including shorter recovery periods, reduced complications, and improved patient comfort.
Common minimally invasive vascular procedures include:
- Atherectomy
- Angioplasty
- Stent placement
- Drug-coated balloon therapy
- Catheter-based interventions
These procedures allow physicians to treat vascular blockages through small incisions, reducing trauma and improving overall patient outcomes. The growing preference for less invasive treatment options among patients and healthcare providers continues to accelerate demand for advanced vascular devices.
Key Growth Drivers of the Peripheral Artery Disease Market
Several factors are driving the continued expansion of the global Peripheral Artery Disease Market.
Rising prevalence of peripheral artery disease
Increasing rates of diabetes, obesity, and cardiovascular risk factors are contributing to a higher number of PAD cases globally. The growing disease burden is increasing demand for effective diagnostic and therapeutic solutions.
Growing adoption of minimally invasive treatments
Patients and physicians increasingly prefer catheter-based procedures due to lower risks, faster recovery, and improved clinical outcomes compared with traditional surgical methods.
Technological advancements in vascular devices
Innovations in atherectomy systems, catheter designs, imaging technologies, and robotic-assisted interventions are improving treatment precision and expanding clinical possibilities.
Increasing healthcare investments
Healthcare systems worldwide are investing in advanced cardiovascular technologies to improve access to vascular care and reduce the burden of chronic cardiovascular diseases.
These factors continue to strengthen the long-term growth prospects of the Peripheral Artery Disease Market.
Discover the Complete Report Here:
https://www.polarismarketresearch.com/industry-analysis/peripheral-artery-disease-market
Key Players
- Abbott
- AngioDynamics
- B. Braun SE
- Bayer AG
- BD
- Biotronik
- Boston Scientific Corporation
- Cardinal Health
- Endologix LLC
- iVascular
- Johnson & Johnson
- Koninklijke Philips N.V.
- Medtronic
- Terumo Corporation
Regional Analysis
North America holds a significant share of the Peripheral Artery Disease Market due to advanced healthcare infrastructure, high cardiovascular disease prevalence, strong adoption of minimally invasive procedures, and continuous investment in medical device innovation.
Europe represents another important market, supported by established vascular care systems, increasing adoption of advanced treatment technologies, and growing awareness regarding peripheral artery disease management.
Asia Pacific is expected to experience strong growth during the forecast period due to rising healthcare expenditure, increasing diabetes prevalence, expanding hospital infrastructure, and growing access to advanced cardiovascular treatments. Emerging economies are increasingly investing in modern vascular intervention technologies to address the rising burden of cardiovascular diseases.
Latin America and the Middle East & Africa are also witnessing gradual market expansion as healthcare modernization initiatives improve access to vascular diagnosis and treatment.
Future Outlook
The future of the Peripheral Artery Disease Market will be shaped by continued advancements in the atherectomy devices market, increasing demand within the cardiovascular disease market, and broader adoption of minimally invasive vascular procedures. Emerging technologies such as artificial intelligence-assisted vascular imaging, robotic catheter systems, advanced drug delivery platforms, and next-generation atherectomy devices are expected to further improve treatment efficiency and patient outcomes.
More Trending Latest Reports By Polaris Market Research:
Healthcare Bioconvergence Market